Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RGEN)

Repligen Reports Third Quarter 2024 Financial Results

GlobeNewswire November 12, 2024

Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewswire November 5, 2024

Repligen to Report Third Quarter 2024 Financial Results

GlobeNewswire October 31, 2024

Repligen Opens Training & Innovation Center to Elevate Customer Experience

GlobeNewswire September 24, 2024

Repligen Corporation to Present at Wells Fargo Healthcare Conference

GlobeNewswire August 23, 2024

Repligen Reports Second Quarter 2024 Financial Results

GlobeNewswire July 30, 2024

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

GlobeNewswire July 29, 2024

Repligen to Report Second Quarter 2024 Financial Results

GlobeNewswire July 16, 2024

The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Contact Them

Accesswire June 20, 2024
View More News ››

Opinion & Analysis (NDAQ:RGEN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RGEN)

Repligen Corporation (NASDAQ:RGEN): Delivering Innovative Bi

http://beyondspx.com/2024/08/02/repligen-corporation-nasdaqrgen-delivering-innovative-biopr
MikeTester - August 3, 2024

Repligen Reports Second Quarter 2024 Financial Results

BREAKING NEWS: $RGEN Repligen Reports Second Quarter 2024 Financial ResultsReports second quarter revenue of $154 million Second quarter...
whytestocks - July 30, 2024

Top 3 Health Care Stocks That Could Blast Off In June | Benz

News; $RGEN Top 3 Health Care Stocks That Could Blast Off In June | BenzingaThe most oversold stocks in the health care sector presents...
whytestocks - June 21, 2024

Repligen Announces CEO Transition Plan

Breaking News: $RGEN Repligen Announces CEO Transition PlanWALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation...
whytestocks - June 13, 2024

Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tue

BREAKING NEWS: $RGEN Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday SessionRepligen Corporation (NASDAQ: RGEN) has...
whytestocks - April 23, 2024

Repligen Reports Fourth Quarter and Full Year 2023 Financial

Breaking News: $RGEN Repligen Reports Fourth Quarter and Full Year 2023 Financial ResultsReports fourth quarter revenue of $156 million...
whytestocks - February 21, 2024
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based intermediate gold producer. The Company is engaged in the acquisition, exploration ...
View More »